Creganna-Tactx Medical is categorized under Business Services (Unclassified) in Minneapolis, MN .
Creganna-Tactx Medical was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Helen Ryan at the company’s branch by writing to 3145 Fernbrook Lane North, Minneapolis, Minnesota MN 55447 or by phoning (763) 201-1360. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Creganna-Tactx Medical |
| Contact Person: | Helen Ryan |
| Address: | 3145 Fernbrook Lane North, Minneapolis, Minnesota 55447 |
| Phone Number: | (763) 201-1360 |
| Website Address: | creganna.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Creganna-Tactx Medical was started in 0 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Helen Ryan for inquiries that concern Creganna-Tactx Medical by calling the company number (763) 201-1360, as your correspondence is most welcome. Additionally, the physical location of the branch of Creganna-Tactx Medical can be found at the coordinates 45.01506,-93.4615 as well as the street address 3145 Fernbrook Lane North in Minneapolis, Minnesota 55447.
For its online presence, you may visit Creganna-Tactx Medical’s website at creganna.com and engage with its social media outlets through on Twitter and on Facebook.